| 1 |
Wang X, Li W, Dong Y, Zhang Y, Huo Q, Lu Lu, Zhang J, Zhao Y, Fan S, Dong H, Li D. Ferrostatin-1 mitigates ionizing radiation-induced intestinal injuries by inhibiting apoptosis and ferroptosis: An in vitro and in vivo study. Int J Radiat Biol 2023;:1-16. [PMID: 36947642 DOI: 10.1080/09553002.2023.2194399] [Reference Citation Analysis]
|
| 2 |
Hu H, Luo J, Liu Y, Li H, Jin R, Li S, Wei J, Wei H, Chen T. Improvement effect of a next-generation probiotic L. plantarum-pMG36e-GLP-1 on type 2 diabetes mellitus via the gut-pancreas-liver axis. Food Funct 2023. [PMID: 36912589 DOI: 10.1039/d3fo00044c] [Reference Citation Analysis]
|
| 3 |
Amit U, Facciabene A, Ben-Josef E. Radiation Therapy and the Microbiome; More Than a Gut Feeling. Cancer J 2023;29:84-8. [PMID: 36957978 DOI: 10.1097/PPO.0000000000000650] [Reference Citation Analysis]
|
| 4 |
Jakubauskas M, Jakubauskiene L, Leber B, Horvath A, Strupas K, Stiegler P, Schemmer P. Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model. Nutrients 2023;15. [PMID: 36904117 DOI: 10.3390/nu15051117] [Reference Citation Analysis]
|
| 5 |
Huang F, Li S, Chen W, Han Y, Yao Y, Yang L, Li Q, Xiao Q, Wei J, Liu Z, Chen T, Deng X. Postoperative Probiotics Administration Attenuates Gastrointestinal Complications and Gut Microbiota Dysbiosis Caused by Chemotherapy in Colorectal Cancer Patients. Nutrients 2023;15. [PMID: 36678227 DOI: 10.3390/nu15020356] [Reference Citation Analysis]
|
| 6 |
Zhao M, Jiang G, Zhou H, Li J, Xiang W, Li S, Wang H, Zhou J. Gut microbiota: a potential target for improved cancer therapy. J Cancer Res Clin Oncol 2023;149:541-52. [PMID: 36550389 DOI: 10.1007/s00432-022-04546-5] [Reference Citation Analysis]
|
| 7 |
Huang N, Li J, Qiao X, Wu Y, Liu Y, Wu C, Li L. Efficacy of probiotics in the management of halitosis: a systematic review and meta-analysis. BMJ Open 2022;12:e060753. [PMID: 36600415 DOI: 10.1136/bmjopen-2022-060753] [Reference Citation Analysis]
|
| 8 |
Manifar S, Koopaie M, Jahromi ZM, Kolahdooz S. Effect of synbiotic mouthwash on oral mucositis induced by radiotherapy in oral cancer patients: a double-blind randomized clinical trial. Support Care Cancer 2022;31:31. [PMID: 36517616 DOI: 10.1007/s00520-022-07521-5] [Reference Citation Analysis]
|
| 9 |
Huang J, Mao Y. The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1029033] [Reference Citation Analysis]
|
| 10 |
Wang Z, Li L, Wang S, Wei J, Qu L, Pan L, Xu K. The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1025860] [Reference Citation Analysis]
|
| 11 |
Ren Z, Hong Y, Huo Y, Peng L, Lv H, Chen J, Wu Z, Wan C. Prospects of Probiotic Adjuvant Drugs in Clinical Treatment. Nutrients 2022;14. [PMID: 36432410 DOI: 10.3390/nu14224723] [Reference Citation Analysis]
|
| 12 |
Liu YC, Wu CR, Huang TW. Preventive Effect of Probiotics on Oral Mucositis Induced by Cancer Treatment: A Systematic Review and Meta-Analysis. Int J Mol Sci 2022;23. [PMID: 36362057 DOI: 10.3390/ijms232113268] [Reference Citation Analysis]
|
| 13 |
Lu Y, Luo X, Yang D, Li Y, Gong T, Li B, Cheng J, Chen R, Guo X, Yuan W. Effects of probiotic supplementation on related side effects after chemoradiotherapy in cancer patients. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1032145] [Reference Citation Analysis]
|
| 14 |
Cheng H, Chen L, Huang M, Hou J, Chen Z, Yang X. Hunting down NLRP3 inflammasome: An executioner of radiation-induced injury. Front Immunol 2022;13:967989. [PMID: 36353625 DOI: 10.3389/fimmu.2022.967989] [Reference Citation Analysis]
|
| 15 |
Bruno JS, Heidrich V, Knebel FH, de Molla VC, Parahyba CJ, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Arrais-Rodrigues C, Camargo AA, Fregnani ER. Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients. Sci Rep 2022;12:17527. [PMID: 36266464 DOI: 10.1038/s41598-022-21775-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Bullard BM, Mcdonald SJ, Cardaci TD, Vanderveen BN, Murphy EA. Nonpharmacological approaches for improving gut resilience to chemotherapy. Current Opinion in Supportive & Palliative Care 2022;16:151-160. [DOI: 10.1097/spc.0000000000000599] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 17 |
Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, Zhao C, Yang L, Xu Z, Dong S, Yu H, Li B, Guan X, Hou Y, Kong FM. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. J Hematol Oncol 2022;15:87. [PMID: 35799264 DOI: 10.1186/s13045-022-01307-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Ting NL, Lau HC, Yu J. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut 2022;71:1412-25. [PMID: 35277453 DOI: 10.1136/gutjnl-2021-326264] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 19 |
Garczyk A, Kaliciak I, Drogowski K, Horwat P, Kopeć S, Staręga Z, Bogdański P, Stelmach-Mardas M, Mardas M. Influence of Probiotics in Prevention and Treatment of Patients Who Undergo Chemotherapy or/and Radiotherapy and Suffer from Mucositis, Diarrhoea, Constipation, Nausea and Vomiting. J Clin Med 2022;11:3412. [PMID: 35743481 DOI: 10.3390/jcm11123412] [Reference Citation Analysis]
|
| 20 |
Dey P, Ray Chaudhuri S. Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches. Biology 2022;11:757. [DOI: 10.3390/biology11050757] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 21 |
Al-qadami G, Van Sebille Y, Bowen J, Wardill H. Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis. Front Oral Health 2022;3:881949. [DOI: 10.3389/froh.2022.881949] [Reference Citation Analysis]
|
| 22 |
Zanetta P, Ormelli M, Amoruso A, Pane M, Azzimonti B, Squarzanti DF. Probiotics as Potential Biological Immunomodulators in the Management of Oral Lichen Planus: What's New? Int J Mol Sci 2022;23:3489. [PMID: 35408849 DOI: 10.3390/ijms23073489] [Reference Citation Analysis]
|
| 23 |
Feng J, Gao M, Zhao C, Yang J, Gao H, Lu X, Ju R, Zhang X, Zhang Y. Oral Administration of Probiotics Reduces Chemotherapy-Induced Diarrhea and Oral Mucositis: A Systematic Review and Meta-Analysis. Front Nutr 2022;9:823288. [DOI: 10.3389/fnut.2022.823288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Bowen J, Wardill H. The science of mucositis. Support Care Cancer 2022. [PMID: 35067733 DOI: 10.1007/s00520-022-06840-x] [Reference Citation Analysis]
|
| 25 |
Mirza MA, Aruna D, Irukulla M. Efficacy of Bacillus clausii UBBC - 07 Spores in the Amelioration of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy. Cancer Treatment and Research Communications 2022. [DOI: 10.1016/j.ctarc.2022.100523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Pimentel TC, da Costa WKA, Tammy Priscilla Chioda D, Sônia Mariza Luiz DO, Katia S, Marciane M. Foods and supplements as probiotic delivery vehicles. Probiotics for Human Nutrition in Health and Disease 2022. [DOI: 10.1016/b978-0-323-89908-6.00005-4] [Reference Citation Analysis]
|
| 27 |
Shetty SS, Maruthi M, Dhara V, de Arruda JAA, Abreu LG, Mesquita RA, Teixeira AL, Silva TA, Merchant Y. Oral mucositis: Current knowledge and future directions. Dis Mon 2021;:101300. [PMID: 34758917 DOI: 10.1016/j.disamonth.2021.101300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 28 |
Wei L, Wen XS, Xian CJ. Chemotherapy-Induced Intestinal Microbiota Dysbiosis Impairs Mucosal Homeostasis by Modulating Toll-like Receptor Signaling Pathways. Int J Mol Sci 2021;22:9474. [PMID: 34502383 DOI: 10.3390/ijms22179474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 29 |
Dietert RR. Microbiome First Medicine in Health and Safety. Biomedicines 2021;9:1099. [PMID: 34572284 DOI: 10.3390/biomedicines9091099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
